CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Affinity Medical Technology

Affinity Medical Technology, LLC is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.

NeuX Technologies

Tampa, Florida - NeuX Technologies is a health, wellness, fitness and human performance company developing proprietary products and solutions for chronic pain, musculoskeletal injuries, neuromuscular conditions/diseases, fitness and human performance.

Valley Regional Medical Center

This is the Home Page for the Website.

Channel Medsystems

Channel Medsystems is a venture-backed company that was founded to bring innovation to the delivery of women’s healthcare. We strive to develop treatments to meet the unique needs of female patients and the high standards of their healthcare providers. We are committed to ensuring that patients have access to high quality outcomes that can be delivered in the convenience and comfort of their healthcare providers office.